Get started
Author

Yuki Haga

Observed names: Haga, Y., YUKI HAGA
Observed institutions: Chiba University, Saint Louis University, Numazu City Hospital, National Hospital Organization Chiba Medical Center, Tokyo Shinjuku Medical Center, Saint Louis University
ORCID: 0000-0002-0070-2091
Observed ORCID: 0000-0002-0070-2091
OpenAlex ID: A5060263711
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma
2020 · Susumu Maruta, Sadahisa Ogasawara, et al. · Liver Cancer · 79
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan
2019 · Sadahisa Ogasawara, Yoshihiko Ooka, et al. · Investigational New Drugs · 79
Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis
2015 · Yuki Haga, Tatsuo Kanda, et al. · World Journal of Gastroenterology · 76
PDF
Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
2017 · Yuki Haga, Tatsuo Kanda, et al. · PLoS ONE · 53
PDF
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
2021 · Keisuke Koroki, Naoya Kanogawa, et al. · Liver Cancer · 44
MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells
2015 · Masato Nakamura, Tatsuo Kanda, et al. · PLoS ONE · 42
PDF
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity
2023 · Tapas Patra, Keith Meyer, et al. · npj Vaccines · 40
PDF
The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells
2015 · Xia Jiang, Tatsuo Kanda, et al. · Biochemical and Biophysical Research Communications · 36
Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis
2017 · Masato Nakamura, Tatsuo Kanda, et al. · PLoS ONE · 35
PDF
Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
2017 · Tatsuo Kanda, Shin Yasui, et al. · International Journal of Molecular Sciences · 32
PDF
Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice
2022 · Miyuki Nakagawa, Masanori Inoue, et al. · Cancer · 29
Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan
2016 · Tatsuo Kanda, Shin Yasui, et al. · International Journal of Medical Sciences · 28
PDF
Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
2015 · Tatsuo Kanda, Shingo Nakamoto, et al. · Journal of Clinical and Translational Hepatology · 28
PDF
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study
2023 · Kazufumi Kobayashi, Sadahisa Ogasawara, et al. · Clinical Cancer Research · 27
The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity
2015 · Tatsuo Kanda, Reina Sasaki, et al. · Biochemical and Biophysical Research Communications · 27
Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κB
2016 · Shuang Wu, Tatsuo Kanda, et al. · International Journal of Molecular Medicine · 26
PDF
Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma
2017 · Tatsuo Kanda, Koji Takahashi, et al. · Cancers · 24
PDF
Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication
2017 · Xia Jiang, Tatsuo Kanda, et al. · Experimental and Therapeutic Medicine · 23
PDF
Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report
2016 · Yuki Ohta, Tatsuo Kanda, et al. · BMC Gastroenterology · 20
PDF
Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells
2016 · Reina Sasaki, Tatsuo Kanda, et al. · PLoS ONE · 20
PDF
Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stress
2014 · XIA JIANG, TATSUO KANDA, et al. · Oncology Reports · 16
PDF
Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin
2017 · Tatsuo Kanda, Masato Nakamura, et al. · Biology · 15
PDF
Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice
2023 · Sae Yumita, Sadahisa Ogasawara, et al. · BMC Gastroenterology · 13
PDF
Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus
2019 · Nan Nwe Win, Tatsuo Kanda, et al. · International Journal of Medical Sciences · 12
PDF
Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin
2016 · Tatsuo Kanda, Shingo Nakamoto, et al. · International Journal of Medical Sciences · 12
PDF
Works count: 89
Citation count: 1,040
H-index: 20
I10-index: 34
Year
Topic
Type